Whitepapers

Whitepaper Dec 12, 2024

Pharma’s AI Dilemma: Balancing Risks and Rewards

Whitepaper Dec 6, 2024

The Cellution to Autoimmunity? The promise and perils of CAR-T

Whitepaper Dec 2, 2024

Navigating Real World Evidence Requirements

Whitepaper Oct 31, 2024

NICE’s Proportional Approach to Technology Appraisals

Whitepaper Aug 5, 2024

Long Follow-Up in Short Supply

Whitepaper Apr 19, 2024

Realize the Full Potential of Your Medical Affairs Team Today by Taking a Holistic Approach to Omnichannel Engagement

Whitepaper Dec 14, 2023

The AI Will See You Now: Opportunities and challenges presented by the use of generative artificial intelligence (AI) across healthcare and the pharma value chain

Whitepaper Dec 11, 2023

Patient Journey Empowerment: Realizing the potential for patients and your brand

Whitepaper Nov 22, 2023

Competitive Planning and Response: Where to focus for sustained success

Whitepaper Nov 21, 2023

Penetrating the CNS – Strategic Implications of an Increasingly Flexible FDA

Whitepaper Nov 14, 2023

Cracking the Code: Unlocking Key Opinion Leaders in the Digital Landscape

Whitepaper Oct 26, 2023

Charting the Course for Biotechnology Commercialization Success: De-risking and Maximizing Regulatory, Access, and Commercial Potential in Europe

Whitepaper Sep 22, 2023

Half-time in the EU HTA Regulation Roll Out

Whitepaper Sep 11, 2023

Before You Start the Strategic Planning Cycle: 5 essential things to streamline your approach

Whitepaper Aug 31, 2023

ICER Value Assessment Framework Update 2023

Whitepaper Aug 11, 2023

Advancing Clinical Development by Strategically Leveraging Advisory Boards

1 2 3 4 5 … 7